Members

The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.

The WGND membership rests with individuals, not institutions. Thus, the WGND has no "lead agency" and is not dominated by any institution or group of institutions. Members represent the private and public sectors and come from diverse geographical locations.

Apply Now Learn More View Core Group

Current Members


Name Organizationsort ascending Country
Kampasati Satyanarayana Yuvabharath Society India
Sang Nae Cho Yonsei University College of Medicine South Korea
Malgosia Grzemska World Health Organization (WHO) Switzerland
Christian Lienhardt World Health Organization (WHO) Senegal
Kobina Bosumtwi Dadzie Wiljok Childaid and Health Organization Ghana
Philip Onyebujoh WHO Regional Office for Africa Zimbabwe
Tamari Trapaidze Welfare Foundation Georgia
Kyu Rhee Weill Cornell Medical College United States
Dirk Schnappinger Weill Cornell Medical College United States
Carl Nathan Weill Cornell Medical College United States
Astrid Van der Sar VU University Medical Center Netherlands
Tiansheng Wang Vertex Pharmaceuticals United States
Michael Cynamon VAMC, SUNY, Upstate Medical University United States
Shashi Kant UT Southwestern Medical Center United States
Norbert Heinrich Universtiy of Munich / PanACEA Germany
David Sherman University of Washington United States
Bavesh Kana University of the Witwatersrand/National Health Laboratory Service South Africa
Andreas Diacon University of Stellenbosch South Africa
Marcio Dias University of Sao Paulo Brazil
Bernard Fourie University of Pretoria South Africa
Anthony Baughn University of Minnesota United States
Sylvie Garneau-Tsodikova University of Michigan United States
Christopher Sassetti University of Massachusetts Medical School United States
Parameshwar Makam University of KwaZulu-Natal South Africa
Oleg Tsodikov University of Kentucky United States
Ute Muh University of Iowa United States
Jonathan Blackburn University of Cape Town South Africa
Payam Nahid University of California, San Francisco United States
Yossef Av-Gay University of British Columbia Canada
Arun Kumar Mishra University of Birmingham United Kingdom
Thomas Dick University in New Jersey UMDNJ-New Jersey Medical School United States
Ibrahim Abubakar University College London, MRC Clinical Trials Unit United Kingdom
Aboubacar Sidiki Daffe Université Cheikh Anta DIOP Senegal
Mario Raviglione Università degli Studi di Milano Switzerland
Amy Bloom United States Agency for International Development (USAID) United States
Joel Freundlich UMDNJ - New Jersey Medical School United States
Joshua Wamboga Uganda Network of AIDS Service Organisations (UNASO) Uganda
Valerie Mizrahi UCT-Institute of Infectious Disease and Molecular Medicine South Africa
Andrew Vernon U.S. Centers for Disease Control and Prevention (CDC) United States
P. R. Narayanan Tuberculosis Research Centre, Chennai (retired) India
Ronan O'Toole Trinity College Dublin Ireland
Mark Harrington Treatment Action Group United States
Erica Lessem Treatment Action Group United States
Kristina Wallengren THINK South Africa
Sanjib Bhakta The Institute of Structural and Molecular Biology, Birkbeck, University of London United Kingdom
William Chamberlin Texas Tech University Health Sciences Center United States
Jeffery Cirillo Texas A&M Health Science Center United States
Dalene von Delft TB Proof South Africa
Asghar Arif TB Association Charsadda Pak Pakistan
Takushi Kaneko TB Alliance United States
Frances Pappas TB Alliance United States
Christo van Niekerk TB Alliance South Africa
Melvin Spigelman TB Alliance United States
Cherise Scott TB Alliance United States
Anna Upton TB Alliance United States
Rajneesh Taneja TB Alliance United States
Klaus Reither Swiss Tropical and Public Health Institute Tanzania
Gill Black Sustainable Livelihoods Foundation South Africa
Edward Berry SUNY Upstate Medical University United States
Gerhard Walzl Stellenbosch University South Africa
Amina Jindani St. George's, University of London United Kingdom
KR John SRM Medical College India
Prasad Pasam Shar Technologies Group India
Carol Nacy Sequella, Inc. United States
Leo Einck Sequella, Inc. United States
Jacques Grosset Scientist France
Fernando Pavan Sao Paulo State University, UNESP, Brazil Brazil
Victoria Kasprowicz SANTHE South Africa
John Szumowski Santa Clara Valley Medical Center United States
Alexandra Carreau Sanofi-Adventis R&D France
Charles Wells Sanofi United States
Brigitte Demers Sanofi France
Didier Leboulleux Sanofi France
Florence Bordon-Pallier Sanofi France
Isabelle Cieren-Puiseux Sanofi France
Doris Rouse RTI International United States
Santiago Ramón García Research Agency of Aragon (ARAID) Spain
Michaela Nielsen Regulatory Affairs Consultant United States
Bob Goldman RCG Consulting United States
Bolin Geng Ra Pharma United States
Dario Scaramuzzi R-Evolution Group EEIG Italy
Daniel Zollinger QareFree Netherlands
Khadar Bhatcha PSG College of Pharmacy India
Teto Fondacaro Mamona Programme National de Lutte Contre la Tuberculose Democratic Republic Of Congo (Zaire)
Nelson Otwoma Positive Familes Network (+FN) Kenya
Chris Dippel Peloton Partnering, SP United States
Claire Wingfield PATH United States
Valerie Flore Donkeng Donfack Pasteur Center in Cameroon Cameroon
Edward Nardell Partners in Health United States
Martin Johan Boeree PanACEA Consortium and the Radboud University Nijmegen Medical Centre Netherlands
Lawrence Geiter Otsuka Pharmaceutical Company United States
Manjunatha Ujjini Novartis Institute for Tropical Diseases Singapore
Avishek Anant Novartis India
Roberto Salvino No affiliation Philippines
Sandeep Saluja No affiliation India
Daniela Jabes NeED Parma Italy
Abdifetah Ibrahim Omer National TB Programme Somalia Somalia
Htay Lwin National TB Program, Myanmar Myanmar (Burma)
Basharat Khan National TB Control Programme Pakistan
Zahoor Ahmed National TB Control Programme Pakistan
Andriy Dudnyk National Medical University of Vinnytsia, Ukraine Ukraine
Liyanage Perera National Institutes of Health (NIH) United States
Helena Boshoff National Institutes of Health (NIH) United States
Rogelio Hernandez Pando National Institute of Medical Sciences and Nutrition, Mexico Mexico
Francisco Leyva National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Sharon Williams National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Gail Tauscher National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Mamodikoe Makhene National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Marina Protopopova National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Clifton Barry National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Jim Boyce National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Barbara Laughon National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Laura Via National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Shekhar Mande National Centre for Cell Science India
Nino Lomtadze National Center for Tuberculosis and Lung Diseases Georgia
Nelly Solomonia National Center for Tuberculosis and Lung Diseases Georgia
Asaad Khalid Ahmed National Center for Research Sudan
Sonja Henne MSF Tunisia
Dhanji Rajani Microcare Laboratory India
Maggie McCammon Michigan Economic Development Corporation United States
Tarek Aboul-Fadl Medicinal Chemistry, Assiut University Egypt
David McNeeley Medical Service Corportation International (MSCI) United States
Renaud Boulanger McGill University Canada
Prasit Palittapongarnpim Mahidol University Thailand
Rajender Kamboj Lupin Limited India
Galyna Kutsyna Luhansk State Medical University Ukraine
Michael Hoelscher Ludwig-Maximilians-University Germany
Richard White London School of Hygiene and Tropical Medicine United Kingdom
Philip Hipskind Lgenia United States
Sang Jae Kim Korean Institute of Tuberculosis South Korea
James Love Knowledge Ecology International (KEI) United States
Martin Graham KinderPharm United States
Steve Wandiga KEMRI/CDC Kenya
Oren Zimhony Kaplan Medical Center, The School of Medicine Hebrew University Israel
Sergey Koren JSC Pharmasyntez Russia
Anil Koul Johnson and Johnson Belgium
Petros Karakousis Johns Hopkins University School of Medicine United States
Shichun Lun Johns Hopkins University School of Medicine United States
Richard Chaisson Johns Hopkins University Center for TB Research United States
Eric Nuermberger Johns Hopkins University United States
Ying Zhang Johns Hopkins University United States
Gyanu Lamichhane Johns Hopkins University United States
William Bishai Johns Hopkins School of Medicine United States
Noroi Doi Japan Anti-Tuberculosis Association (JATA) Research Institute of TB Japan
Tado Shimao Japan Anti-Tuberculosis Association (JATA) Research Institute of TB Japan
Koen Andries Janssen Belgium
Chris Edlin iThemba Pharmaceuticals South Africa
Roger Moses iThemba Pharmaceuticals United Kingdom
Dorothy Odhiambo International Community of Women Living with HIV in Kenya ( ICW-K) Kenya
Kanury Rao International Centre for Genetic Engineering & Biotechnology-New Delhi India
Hugo Cesar Gramajo Instituto de Biologia Molecular y Celular de Rosario Argentina
Scott Franzblau Institute for Tuberculosis Research, University of Illinois at Chicago United States
Kevin Pethe Institut Pasteur-Korea South Korea
Nicolas Willand Institut Pasteur Lille France
Stewart Cole Institut Pasteur Switzerland
Pere-Joan Cardona Institut Germans Trias i Pujol (IGTP) Spain
Iain Old Innovative Medicines for TB (iM4TB) Switzerland
Tanya Parish Infectious Disease Research Institute (IDRI) United States
Gail Cassell Infectious Disease Research Institute (IDRI) United States
Allen Casey Infectious Disease Research Institute (IDRI) United States
Brian Robertson Imperial College London United Kingdom
Ann Ginsberg IAVI United States
James Frincke Hollis Eden Pharmaceuticals United States
Polly Clayden HIV i-Base United Kingdom
Matthew Price Harvard School of Public Health United States
Carole Mitnick Harvard Medical School United States
Alick Chimpimo Makiyi Grassroots Movement for Health and Development (GMHD) Malawi
Muhammad Farooq Government of Pakistan Pakistan
Samir Roy Government Medical College, Bhavnagar India
Bonita Mangura Global TB Institute at UMDNJ United States
Stephen Matlin Global Forum for Health Research Switzerland
Christopher Cooper Global Alliance for TB Drug Development (TB Alliance) United States
Lluís Ballell GlaxoSmithKline Tres Cantos Spain
Robert Bates GlaxoSmithKline Spain
Oscar Della Pasqua GlaxoSmithKline United Kingdom
David Barros GlaxoSithKline Spain
Nii Nortey Hanson-Nortey Ghana Health Service Ghana
Mohammad Hassan Mashori Fundamental Human Rights & Rural Development Association (FHRRDA) Pakistan
Doug Lowrie Fudan University's Shanghai Public Health Clinical Center China
Xuelian Zhang Fudan University China
Jing Bao Frontier Biotechnologies, LLC United States
Maria Freire Foundation for NIH United States
Christine Sizemore Fogarty International Center at NIH United States
Carol Dukes Hamilton Family Health International United States
Wim Vandevelde European AIDS Treatment Group (EATG); Community Representative South Africa
Jurriaan de Steenwinkel Erasmus MC Netherlands
Yap Boum II Epicentre/MSF Uganda
Kenneth Castro Emory University United States
Neeraj Dhar École Polytechnique Fédérale de Lausanne (EPFL) Switzerland
Todd Waldman Easton Associates United States
Anneke Hesseling Desmond Tutu TB Centre South Africa
Tanjore Balganesh CSIR-OSDD India
Ravishankar Ramachandran CSIR-Central Drug Research Institute, Lucknow, India India
Boitumelo Semete Council of Scientific Industrial Research (CSIR) in South Africa South Africa
Hulda Swai Council of Scientific Industrial Research (CSIR) in South Africa South Africa
David Russell Cornell University United States
Brian VanderVen Cornell University United States
Albert Makone Community Representative; Global Fund (local) Zimbabwe
Josef Jampilek Comenius University Slovakia
Mary Jackson Colorado State University United States
Mary Ann de Groote Colorado State University United States
Diane Ordway Colorado State University United States
Anne Lenaerts Colorado State University United States
Barry Bunin Collaborative Drug Discovery United States
Regina Osih Clinton Health Access Initiative South Africa
Shreemanta Parida Clinical Scientist India
Masaji Okada Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center Japan
Robert Husson Children's Hospital Boston/Harvard Medical School United States
Martin Dolezal Charles University in Prague, Faculty of Pharmacy in Hradec Kralove Czech Republic
Sidharth Chopra Central Drug Research Institute, Lucknow India
Benson Muriuki Center for the Empowerment Of The Local Herbalist-Celoh Kenya Kenya
Jerome Zeldis Celgene United States
Shashank Gupta Brown University United States
C. Robert Horsburgh Boston University School of Public Health United States
Juan David Guzman Birkbeck College United Kingdom
Marc Gitzinger BioVersys AG Switzerland
Yadav Prasad Joshi Biodyss and Journal Infection in Developing Countries France
Khisimuzi Mdluli Bill and Melinda Gates Medical Research Institute United States
Debra Hanna Bill and Melinda Gates Foundation United States
Omar Vandal Bill and Melinda Gates Foundation United States
Peter Warner Bill and Melinda Gates Foundation United States
Ken Duncan Bill & Melinda Gates Foundation United States
Cathy Bansbach Bill & Melinda Gates Foundation United States
Jan Gheuens Bill & Melinda Gates Foundation United States
Tawanda Gumbo Baylor University United States
Martin Springsklee Bayer Healthcare United States
Christopher Locher Baxalta United States
Simon Tiberi Barts Healthcare NHS Trust United Kingdom
Gary Horwith BARDA United States
Robert Wallis Aurum Institute South Africa
Hiromu Kawakubo Asahi Kasei Chemicals Corporation Japan
Ahmadul Khan Ahmadul Hasan Khan Bangladesh
Joan A. Cayla Agència de Salut Pública de Barcelona Spain
Kolawole Ekanoye Advocates for Health and Development Initiative Nigeria
Heinz Moser Achaogen United States
Gilla Kaplan United States
Rick O'Brien Switzerland

New Members


The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.

Apply Now

Questions? Contact Us